L upus is a complex autoimmune disease that can affect almost any organ in the body 1 . Brain dysfunction develops in many people with the disease, but the molecular and cellular basis for this aspect of the condition are poorly understood, and there are no therapies that target it. On page 539, Bialas et al. 2 provide insight into how brain disease can occur in mouse models of lupus, and bring a potential therapeutic target into focus.
Type I interferon proteins and their receptor are part of a pathway that has a pivotal role in the immune response against viral infection. Compared with healthy individuals, people who have an impaired type I interferon response can be prone to infections, whereas individuals who have an overactive response might have autoimmune disease or organ damage associated with inflammation 3, 4 . Abnormal activation of the type I interferon response is observed in most people with lupus, and a clinical study 5 found that interferon-related gene expression correlates with specific disease features.
Bialas and colleagues investigated previously established mouse models of lupus in which there is activation of the type I interferon response 6 . The authors observed that such mice show significant neurological deficits, including poor performance on cognitive and behavioural tasks compared with wildtype animals. However, treating the model mice with an antibody that blocks signalling through the type I interferon receptor prevents these neurological symptoms.
The authors sought to determine which cells might be responsible for this phenomenon. In many diseases associated with neuroinflammation, immune cells enter the brain. However, Bialas et al. found no evidence of such infiltration in the brains of the model mice. This finding indicates that the cells causing neurological damage might originate in the brain itself.
Microglia, the resident immune cells of the brain, were considered a prime suspect. These cells perform many immunological roles, including the active surveillance of their environment, and through a process called engulfment they can ingest cellular material. Inflammation and the presence of cellular damage can stimulate microglia to adopt an activated state associated with an increase in the activity of immune functions, including engulfment. The authors found that microglia were in an activated state throughout the brains of the model mice, and were responding to signalling by type I interferon.
Using the model mice, Bialas and colleagues purified microglial cells and sequenced the cellular RNA. Relative to the expression patterns observed in wild-type mice, the model mice showed upregulation of a broad set of interferon-dependent genes, including those involved in pathways associated with environmental sensing and the engulfment of cellular mater ial. In a series of elegant experiments, the authors demonstrated an association between the observed microglial activation and an increased engulfment of neuronal material, particularly of mater ial from synapses, which form the junctions between two neurons. The use of electron microscope imaging enabled the authors to catch microglia in the act of synaptic ingestion.
The number, or density, of synapses was found to be decreased in the brains of the lupus-model mice, when compared with the this could not be proved experimentally with the tools at hand.
Extensions of the work that address these issues and others will be eagerly anticipated. In particular, it will be fascinating to see what happens when there are many particles, when new geometries or the dimensionality of the particles' environment are engineered, or when different kinds of interactions between particles are applied. ■ 
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Synapses pruned in lupus
Lupus is an autoimmune disease that can cause brain dysfunction. Studies in mouse models of lupus find that interferon proteins can cause the brain's immune cells to trim the synaptic connections between neurons. See Letter p.539 2 investigated the brain inflammation that can occur as a feature of an autoimmune disease called lupus. The authors used previously established 6 mouse strains that provide models for studying the disease. These animals have a higher level of interferon than do wild-type animals. Bialas and colleagues observed that the microglial cells in the model mice adopted an activated state that involved activation of immune functions, including the ingestion of cellular material through a process known as engulfment. Using image analysis, the authors observed that the activated microglial cells ingested synaptic material from neurons, resulting in a reduced synaptic density compared with that of wild-type animals. This change to the synapses could be prevented by blocking activation of the interferon pathway (not shown). 
B J O R N ST E V E N S
A difficult question that has preoccupied generations of climate scientists is how strongly the human contribution to aerosols -suspensions of particulate matter in the atmosphere -influences climate. Aerosols reflect the Sun's rays back to space and cool Earth's surface, like a planetary parasol. The human contribution to this effect is described by a quantity called aerosol forcing, which measures the aerosol perturbation in units of energy, allowing it to be compared to other climate 'forcings' such as those from greenhouse gases 1 . On page 485, Malavelle et al. 2 use the 2014-15 volcanic eruption in Holuhraun, Iceland (Fig. 1) , as a natural experiment to quantify how the influence of aerosols (in this case, formed from volcanic emissions such as sulfur dioxide, SO 2 ) on clouds contributes to aerosol forcing. Consistent with a growing chorus of other studies [3] [4] [5] [6] [7] [8] [9] , and in contrast to what is assumed in many climate models, they find little evidence that clouds mediate a strong aerosol forcing.
Early studies [10] [11] [12] focused on how aerosols interact with radiation directly, and first raised the spectre of a large aerosol forcing -so large, according to one study, that it would prematurely lead Earth to the next ice age 10 . It has since become clear 3, 13 that factors that were neglected or discounted led these studies to greatly overstate the contribution of aerosolradiation interactions to aerosol forcing. Less clear has been how aerosol-cloud interactions influence this forcing 14 .
As water condenses in a particulate-laden atmosphere, it distributes itself across more condensation sites than it would in unpolluted skies. Consequently, cloud droplets are smaller but more numerous, and a larger proportion of sunlight is reflected back to space, so aerosol-cloud interactions might make an additional contribution to aerosol forcing. Furthermore, smaller cloud particles could delay the onset of rain, allowing clouds to last longer and become more widespread -a mechanism called the cloud-lifetime effect 5, 14 . These effects and others have sustained the spectre of a substantial aerosol forcing.
I say 'spectre' because if the aerosol parasol is sufficiently large, then the cooling effect of forcing from aerosols must have been comparable in magnitude, but opposite in sign, to the warming from greenhouse gases for much of the past century. This would imply that the observed increase in globally averaged surface temperatures over this time period was driven by a relatively small overall forcing. It would then follow that Earth's surface temperature is extremely sensitive to forcing, and efforts to regulate aerosol precursors such as SO 2 would lead to strong and rapid warming 15 . It is in this sense that scientists 'feared' a large aerosol forcing -so much so that, as emissions of aerosols and aerosol precursors began to wane in the 1980s, interest in their climatic effect waxed 12 .
Rather than accepting the idea that aerosols influence clouds, Malavelle and colleagues decided to test it. Extending the work of a previous study 16 , the authors used the Holuhraun eruption as a natural experiment to link changes in cloudiness to changes in aerosols. At its peak, Holuhraun is estimated 2, 17 to have emitted SO 2 at rates comparable to total emissions by Europeans or North Americans in the 1970s. Because Holuhraun was a fissure eruption -in which emissions come from cracks (fissures) along the volcano's sides -its SO 2 synaptic density in wild-type mice (Fig. 1) . These abnormalities could be prevented by blocking interferon signalling. Although determining whether this mechanism causes disease in humans remains a challenge for the future, the authors do show evidence of widespread activation of an interferon response in microglia and other cell types in the brains of people with lupus. Perhaps, in addition to the microglia-mediated mechanisms seen in the mouse models, humans have other cellular targets through which interferon can cause brain disease.
These findings have implications for understanding core neurobiological processes, as well as offering insights of clinical relevance. Synaptic pruning by microglial cells was originally described as a mechanism that helps to sculpt neuronal circuits in the developing brain 7 . Subsequent discoveries have implicated synaptic pruning as a pathological mechanism associated with the early stages of some neuro degenerative diseases 8 . The finding that inflammatory factors such as type I interferon can modulate neuronal connectivity will doubtless provoke further debate surrounding the expanding list of potential roles for microglial-mediated synaptic pruning in brain health and disease.
The current study adds to the growing scientific rationale for classifying lupus brain disease according to the molecular mechanism involved 5 . This is because it is becoming increasingly clear that neurological disease in lupus is heterogeneous and can be driven by distinct molecular mechanisms. For example, some people with lupus develop brain disease associated with antibodies that bind to proteins expressed on the surface of neuronal cells 9 , whereas the work by Bialas and colleagues adds to an increasing body of evidence pointing to type I interferon as having a neurotoxic role 3, 4, 10 . Clinical trials of targeted therapies are much needed for lupus-associated neurological disease. The ability to group patients according to the molecular mechanisms that drive their disease should facilitate such studies and maximize the chance of treatment success.
The tools for studying the therapeutic modulation of type I interferon signalling in people with lupus continue to increase in precision 11 . Consideration should be given to the most effective strategy for modulating this pathway in the human brain, because the blood-brain barrier poses particular challenges for the access of drug treatments. Moreover, therapeutic blockade of type I interferon signalling in the brain is not without potential risks, given the pivotal role of this pathway in host defence and the need for a 
